Skip to Content


Today, new and affordable genetic testing allows us to more precisely determine an individual’s likelihood to develop disease and respond to specific treatments. The integration of DNA and health histories is helping to uncover a seismic new layer of knowledge that can predict, prevent and treat a variety of conditions—revolutionizing the practice of medicine.

At NorthShore we’ve been at the forefront of utilizing innovative techniques and technologies to help improve patient care and outcomes for decades. From identifying the first case of swine flu in Illinois, to leading the nation in developing a customized medical therapy option for lung cancer based on advanced tumor sequencing, our translational capabilities put us in a unique position to make significant advancements in the field of personalized medicine.

The recent implementation of state-of-the-art Next Generation Sequencing (NGS) has added another exciting dimension to our research endeavors. In less time and at lower costs, we can now conduct more extensive DNA analyses. This leading-edge technology allows our investigators to ask many more research questions in hopes of more quickly finding the answers to treating and preventing complex diseases and conditions.

The Mark R. Neaman Center for Personalized Medicine has a strong commitment to leading-edge research and collaborative clinical trials that ultimately provide direct benefits to our patients. These groundbreaking discoveries lead to:

  • Improved care through more effective screening and treatment options
  • Precise medical dosing amounts to significantly reduce adverse effects
  • Increased patient safety measures against infection and common illnesses
  • Reduced costs due to less trial and error with treatments and medications

Leading novel studies to further advance the individualized care of our patients, NorthShore continues to introduce and expand upon a variety of exciting personalized medicine research projects, including, but not limited to: